JP2007521244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007521244A5 JP2007521244A5 JP2005510644A JP2005510644A JP2007521244A5 JP 2007521244 A5 JP2007521244 A5 JP 2007521244A5 JP 2005510644 A JP2005510644 A JP 2005510644A JP 2005510644 A JP2005510644 A JP 2005510644A JP 2007521244 A5 JP2007521244 A5 JP 2007521244A5
- Authority
- JP
- Japan
- Prior art keywords
- desmopressin
- serum
- dosage form
- plasma
- pharmaceutical dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 claims 17
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 claims 17
- 229960004281 desmopressin Drugs 0.000 claims 17
- 210000002381 plasma Anatomy 0.000 claims 10
- 210000002966 serum Anatomy 0.000 claims 10
- 239000002552 dosage form Substances 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 210000002700 urine Anatomy 0.000 claims 3
- 208000008967 Enuresis Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- 206010029446 nocturia Diseases 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 208000031220 Hemophilia Diseases 0.000 claims 1
- 208000009292 Hemophilia A Diseases 0.000 claims 1
- 206010021639 Incontinence Diseases 0.000 claims 1
- 208000003450 Neurogenic Diabetes Insipidus Diseases 0.000 claims 1
- 208000027276 Von Willebrand disease Diseases 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 239000012876 carrier material Substances 0.000 claims 1
- 208000028235 central diabetes insipidus Diseases 0.000 claims 1
- 201000010064 diabetes insipidus Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 201000005119 neurohypophyseal diabetes insipidus Diseases 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/035662 WO2005046707A1 (en) | 2003-11-10 | 2003-11-10 | Pharmaceutical compositions including low dosages of desmopressin |
Related Child Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011024804A Division JP2011116764A (ja) | 2011-02-08 | 2011-02-08 | 低用量デスモプレシンを含有する医薬組成物 |
| JP2014131839A Division JP2014177491A (ja) | 2014-06-26 | 2014-06-26 | 低用量デスモプレシンを含有する医薬組成物 |
| JP2014133867A Division JP6341777B2 (ja) | 2014-06-30 | 2014-06-30 | 低用量デスモプレシンを含有する医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007521244A JP2007521244A (ja) | 2007-08-02 |
| JP2007521244A5 true JP2007521244A5 (enExample) | 2007-11-01 |
| JP5596252B2 JP5596252B2 (ja) | 2014-09-24 |
Family
ID=34589310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005510644A Expired - Fee Related JP5596252B2 (ja) | 2003-11-10 | 2003-11-10 | 低用量デスモプレシンを含有する医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| EP (6) | EP2322198A2 (enExample) |
| JP (1) | JP5596252B2 (enExample) |
| CN (1) | CN1878563A (enExample) |
| AU (1) | AU2003287591C1 (enExample) |
| CA (2) | CA2545194C (enExample) |
| WO (1) | WO2005046707A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| EP2322198A2 (en) | 2003-11-10 | 2011-05-18 | Reprise Biopharmaceutics, LLC | Pharmaceutical compositions including low dosages of desmopressin |
| DE60305043T2 (de) | 2003-11-13 | 2006-11-30 | Ferring B.V. | Blisterverpackung und feste Dosierungsform enthaltend Desmopressin |
| SE528446C2 (sv) * | 2006-03-02 | 2006-11-14 | Ferring Int Ct Sa | Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse |
| WO2008104366A1 (en) | 2007-02-27 | 2008-09-04 | Ivax Pharmaceuticals Ireland | Metered-dose inhaler |
| US8399410B2 (en) * | 2007-08-06 | 2013-03-19 | Allergan, Inc. | Methods and devices for desmopressin drug delivery |
| ES2319054B1 (es) | 2007-08-06 | 2010-02-12 | Gp Pharm S.A. | Composicion farmaceutica oral de desmopresina. |
| US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
| SI3225250T1 (sl) * | 2008-05-21 | 2019-11-29 | Ferring Bv | Orodisperzibilen dezmopresin za podaljšanje začetnega obdobja spanja, ki ga ne moti nokturija |
| US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
| CA2747998C (en) * | 2008-12-22 | 2016-05-31 | Allergan, Inc. | Safe desmopressin administration |
| MX343193B (es) | 2009-06-18 | 2016-10-26 | Allergan Inc | Administracion segura de desmopresina. |
| MX2016001032A (es) * | 2013-07-23 | 2017-10-31 | Allergan Inc | Metodos y composiciones que comprenden desmopresina en combinacion con un inhibidor de 5-alfa reductasa. |
| DK3024474T3 (da) * | 2013-07-23 | 2022-03-28 | Serenity Pharmaceuticals Llc | Sammensætninger omfattende desmopressin i kombination med en beta-3-adrenoreceptor-agonist |
| WO2015063602A1 (en) * | 2013-10-29 | 2015-05-07 | Ferring B.V. | Desmopressin and blood glucose |
| EP3220942B1 (en) * | 2014-11-20 | 2022-04-27 | Serenity Pharmaceuticals LLC | Compositions comprising low dose desmopressin in combination with an alpha-adrenergic receptor antagonist |
| JP6467071B2 (ja) * | 2016-01-29 | 2019-02-06 | 小林 光 | 固形製剤、固形製剤の製造方法及び水素発生方法 |
| CN110191699A (zh) | 2016-08-23 | 2019-08-30 | 小林光 | 氢供给材料与其制造方法、及氢供给方法 |
| US11707063B2 (en) | 2016-08-23 | 2023-07-25 | Bosquet Silicon Corp. | Compound, production method therefor, and hydrogen supply method |
| KR20190104322A (ko) * | 2017-01-11 | 2019-09-09 | 훼링 비.브이. | 속붕해성 약학적 조성물 |
| CN114432424B (zh) * | 2021-12-27 | 2023-06-27 | 南通联亚药业股份有限公司 | 一种稳定的铝塑包装去氨加压素片剂 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4072668A (en) | 1973-11-06 | 1978-02-07 | The Salk Institute For Biological Studies | LH-RH Analogs |
| GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| US4285858A (en) * | 1979-10-30 | 1981-08-25 | Mt. Sinai School Of Medicine Of The City University Of N.Y. | Vasopressin analogs |
| IE53696B1 (en) | 1981-12-02 | 1989-01-18 | Wyeth John & Brother Ltd | Solid shaped articles |
| GB2111423B (en) | 1981-12-02 | 1985-06-26 | Wyeth John & Brother Ltd | Making quick-dissolving pills |
| ATE14047T1 (de) | 1981-12-11 | 1985-07-15 | Wyeth John & Brother Ltd | Verfahren und vorrichtung zum gefrieren einer fluessigkeit. |
| ATE24964T1 (de) | 1981-12-11 | 1987-01-15 | Wyeth John & Brother Ltd | Verfahren zur herstellung von festen formgegenstaenden. |
| US5188825A (en) | 1989-12-28 | 1993-02-23 | Iles Martin C | Freeze-dried dosage forms and methods for preparing the same |
| NZ246091A (en) | 1991-12-24 | 1995-08-28 | Yamanouchi Pharma Co Ltd | Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol |
| IL105553A (en) | 1992-05-06 | 1998-01-04 | Janssen Pharmaceutica Inc | Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water |
| ATE193892T1 (de) * | 1993-06-29 | 2000-06-15 | Ferring Bv | Synthese zyklischer peptide |
| US5500413A (en) * | 1993-06-29 | 1996-03-19 | Ferring Ab | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
| US5631023A (en) | 1993-07-09 | 1997-05-20 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
| US5738875A (en) | 1994-10-28 | 1998-04-14 | R.P. Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| US5837287A (en) | 1994-10-28 | 1998-11-17 | R P Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| GB9421836D0 (en) | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
| US5989835A (en) * | 1997-02-27 | 1999-11-23 | Cellomics, Inc. | System for cell-based screening |
| US5968895A (en) | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| GB9702799D0 (en) | 1997-02-12 | 1997-04-02 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms |
| US5925730A (en) | 1997-04-11 | 1999-07-20 | Ferring Bv | GnRH antagonists |
| US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| US5976577A (en) | 1997-07-11 | 1999-11-02 | Rp Scherer Corporation | Process for preparing fast dispersing solid oral dosage form |
| GB9722682D0 (en) | 1997-10-27 | 1997-12-24 | Scherer Ltd R P | Pharmaceutical products |
| US6200604B1 (en) | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
| GB9901819D0 (en) | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
| GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
| DE10001390A1 (de) | 2000-01-14 | 2001-07-19 | Hepavec Ag Fuer Gentherapie | Zelllinie zur Herstellung und Produktion von Schafadenovirusvektoren |
| GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| CA2484724C (en) * | 2002-05-07 | 2007-01-16 | Ferring B.V. | Pharmaceutical formulations |
| EP2322198A2 (en) | 2003-11-10 | 2011-05-18 | Reprise Biopharmaceutics, LLC | Pharmaceutical compositions including low dosages of desmopressin |
-
2003
- 2003-11-10 EP EP11000468A patent/EP2322198A2/en not_active Withdrawn
- 2003-11-10 EP EP11000467A patent/EP2322197A2/en not_active Withdrawn
- 2003-11-10 CA CA2545194A patent/CA2545194C/en not_active Expired - Lifetime
- 2003-11-10 AU AU2003287591A patent/AU2003287591C1/en not_active Ceased
- 2003-11-10 WO PCT/US2003/035662 patent/WO2005046707A1/en not_active Ceased
- 2003-11-10 CN CNA2003801106751A patent/CN1878563A/zh active Pending
- 2003-11-10 EP EP03781836A patent/EP1689419A4/en not_active Withdrawn
- 2003-11-10 EP EP11000464A patent/EP2322194A2/en not_active Withdrawn
- 2003-11-10 EP EP11000465A patent/EP2322195A2/en not_active Withdrawn
- 2003-11-10 JP JP2005510644A patent/JP5596252B2/ja not_active Expired - Fee Related
- 2003-11-10 CA CA2866501A patent/CA2866501A1/en not_active Abandoned
- 2003-11-10 EP EP11000466A patent/EP2322196A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007521244A5 (enExample) | ||
| KR100760536B1 (ko) | 급성 장해 치료용 약제학적 조성물 | |
| KR101503074B1 (ko) | 소용량 경구 경점막 투여 형태 | |
| KR100760531B1 (ko) | 급성 통증 치료용 펜타닐 조성물 | |
| JP2004504406A5 (enExample) | ||
| Alanazi et al. | Formulation and physicochemical characterisation of buccoadhesive films containing ketorolac | |
| JP2009535397A (ja) | 経粘膜的組成物 | |
| JP2007513190A5 (enExample) | ||
| EP1587514A1 (en) | A rapid-acting pharmaceutical composition | |
| CA2513567A1 (en) | Cop 1 for treatment of inflammatory bowel diseases | |
| KR20080084858A (ko) | 구강 경점막 전달을 위한 생접착성 약물 제형 | |
| WO2002067903A3 (en) | Compositions and methods of manufacture for oral dissolvable dosage forms | |
| JP5611033B2 (ja) | ポリペプチドの経粘膜送達組成物 | |
| CN100594936C (zh) | 改善透粘膜给药制剂的吸收的方法 | |
| TW200836738A (en) | Improvements in or relating to medicinal compositions | |
| US20030153590A1 (en) | Method of treating alcoholism or alcohol abuse | |
| JP2007524616A (ja) | Ｈｉｖを処置するための組成物および方法 | |
| WO2003037272A3 (en) | Thymosin alpha 1 peptide/polymer conjugates | |
| WO2004006929A1 (ja) | 経鼻吸収用組成物 | |
| CA2470235A1 (en) | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | |
| CA2547873A1 (en) | Tetrapeptide regulating blood glucose level in diabetes mellitus | |
| WO2024016113A1 (en) | Sublingual mucus adhesion drug delivery | |
| JP2660333B2 (ja) | 抗利尿剤 | |
| HK1148458B (en) | Pharmaceutical composition comprising fentanyl for the treatment of acute or breakthrough pain by sublingual administration |